What You Should Know:
– Validose, a 10XBeta Venture Studio portfolio company pioneering precision medication delivery, announced today the successful close of a $2 million pre-seed funding round.
– The round was led by Peter Bauer’s Family Office as part…
Continue Reading
Revolutionary Findings in Breast Cancer Screening
A landmark clinical trial has revolutionized breast cancer screening by demonstrating the remarkable effectiveness of artificial intelligence in mammography. The Mammography Screening with Artificial Intelligence (MASAI) trial, published in…
What You Should Know:
– myTomorrows, a global health technology company connecting patients and physicians with all possible pre-approval treatment options, today announced the launch of its next-generation AI platform.
– Designed to streamline clinical trial…
Continue Reading
What You Should Know:
– Cognizant (Nasdaq: CTSH) announced an expanded agreement with Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, to provide support for Medidata’s life sciences clients and expand the…
Continue Reading
What You Should Know:
– Owkin, an AI-powered biotech company, today announced the dosing of the first patient in its Phase I clinical trial of OKN4395, a novel cancer therapy designed to restore immune function…
Continue Reading
Groundbreaking AI Study Transforms Cancer Diagnostics
Lunit, in partnership with Japan’s National Cancer Center Hospital East (NCCHE), has published breakthrough research in the Journal of Clinical Oncology Precision Oncology. Their study demonstrates how AI-powered pathology…
Background: HIV continues to be a public health concern for Mexico and Latin America due to an increase in new cases, instead of a decrease, such as is observed globally. Treatment adherence is a…
Continue Reading
What You Should Know:
– Inato, the leading platform for clinical trial access and inclusivity, today unveiled new capabilities to help research sites efficiently pre-screen patients for trial opportunities.
– The company’s latest advancement integrates a…
Continue Reading
What You Should Know:
– Lindus Health, a company transforming the clinical trial landscape with its tech-first approach raises $55M in Series B funding round led by Balderton Capital, with participation from Visionaries Club and…
Continue Reading
Premature frailty is a critical challenge for young breast cancer survivors (YBCSs), impacting their health and perpetuating gender inequality through heightened vulnerability and marginalization. While digital health shows promise in frailty screening, its effectiveness…
Continue Reading
